本页面由Tiger Trade Technology Pte. Ltd.提供服务

Belite Bio, Inc.

158.59
+4.102.65%
盘后:158.590.00000.00%19:30 EDT
成交量:25.92万
成交额:4,110.28万
市值:63.87亿
市盈率:-57.92
高:160.74
开:154.95
低:154.63
收:154.49
52周最高:200.00
52周最低:77.64
股本:4,027.21万
流通股本:1,955.07万
量比:1.72
换手率:1.33%
股息:- -
股息率:- -
每股收益(TTM):-2.7382
每股收益(LYR):-2.3141
净资产收益率:-22.10%
总资产收益率:-15.65%
市净率:8.22
市盈率(LYR):-68.53

数据加载中...

2026/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/31

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/01/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/10/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/21

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans